Pursuant to Regulation 30 and other applicable provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Asston Pharmaceuticals has enclosed the outcome and proceedings of the Extraordinary General Meeting of Asston Pharmaceuticals held on Friday, 31st July, 2026 at 12.30 PM through Video Conferencing (VC) facility /Other Audio Visual Means (OAVM).
The above information is a part of company's filings submitted to BSE.
